A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation

키워드

참고문헌 (70)

1. Song Young Goo, "COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis", Infection and Chemotherapy, 52(1), pp.110~112 (2020), 대한감염학회[DOI]
2. Lax SF, "Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series", Ann Intern Med (2020)
3. Wu F, "A new coronavirus associated with human respiratory disease in China", Nature, 579, pp.265~269 (2020)
4. Inoue Y, "Acute inflammatory and immunologic responses against antigen in chronic bird-related hypersensitivity pneumonitis", Allergol Int, 68, pp.321~328 (2019)
5. Mackiewicz B, "Acute hypersensitivity pneumonitis in woodworkers caused by inhalation of birch dust contaminated with Pantoea agglomerans and Microbacterium barkeri", Ann Agric Environ Med, 26, pp.644~655 (2019)
6. Metzger F, "Hypersensitivity pneumonitis due to molds in a saxophone player", Chest, 138, pp.724~726 (2010)
7. Sahin H, "Hypersensitivity pneumonitis", Semin Roentgenol, 54, pp.37~43 (2019)
8. Cormier Y, "The role of viruses in the pathogenesis of hypersensitivity pneumonitis", Curr Opin Pulm Med, 6, pp.420~423 (2000)
9. Dakhama A, "Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis", Am J Respir Crit Care Med, 159, pp.1316~1322 (1999)
10. Gudmundsson G, "Viral infection modulates expression of hypersensitivity pneumonitis", J Immunol, 162, pp.7397~7401 (1999)
11. Fernández Pérez ER, "Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis", Chest, 144, pp.1644~1651 (2013)
12. Watts MM, "Hypersensitivity pneumonitis", Allergy Asthma Proc, 40, pp.425~428 (2019)
13. D'souza RS, "Hypersensitivity pneumonitis : an overlooked cause of cough and dyspnea", J Community Hosp Intern Med Perspect, 7, pp.95~99 (2017)
14. Chandra D, "Hypersensitivity Pneumonitis. StatPearls. Treasure Island (FL)" (2020), StatPearls Publishing StatPearls Publishing LLC
15. Magee AL, "Imaging of hypersensitivity pneumonitis", Radiol Clin North Am, 54, pp.1033~1046 (2016)
16. Shi H, "Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China : a descriptive study", Lancet Infect Dis, 20, pp.425~434 (2020)
17. Miller WT Jr, "Isolated diffuse ground-glass opacity in thoracic CT : causes and clinical presentations", AJR Am J Roentgenol, 184, pp.613~622 (2005)
18. Silva CIS, "Hypersensitivity pneumonitis : spectrum of high-resolution CT and pathologic findings", AJR Am J Roentgenol, 188, pp.334~344 (2007)
19. Yoshizawa Y, "The significance of complement activation in the pathogenesis of hypersensitivity pneumonitis : sequential changes of complement components and chemotactic activities in bronchoalveolar lavage fluids", Int Arch Allergy Appl Immunol, 87, pp.417~423 (1988)
20. Regal JF, "Role of the complement system in pulmonary disorders", Immunopharmacology, 38, pp.17~25 (1997)
21. Gralinski LE, "Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis", MBio, 9, pp.e01753~e01818 (2018)
22. Domachowske JB, "Recombinant human eosinophil-derived neurotoxin", RNase 2 functions as an effective antiviral agent against respiratory syncytial virus, 1998, pp.177, 1458~1464
23. Goff PH, "Synthetic toll-like receptor 4(TLR4)and TLR7 ligands work additively via MyD88 to induce protective antiviral immunity in mice", J Virol, 91, pp.e01050~e01117 (2017)
24. Li Y, "Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response", Microbes Infect, 15, pp.88~95 (2013)
25. McGonagle D, "The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease", Autoimmun Rev, 19, pp.102537~ (2020)
26. Phipps S, "Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus", Blood, 110, pp.1578~1586 (2007)
27. Li CK, "T cell responses to whole SARS coronavirus in humans", J Immunol, 181, pp.5490~5500 (2008)
28. Bouadma L, "Immune alterations during SARS-CoV-2-related acute respiratory distress syndrome", medRxiv 2020:2020.05.01.20087239, ~ (2020)
29. Soler P, "Role of mast cells in the pathogenesis of hypersensitivity pneumonitis", Thorax, 42, pp.565~572 (1987)
30. Cheng Y, "Eosinopenia phenotype in patients with coronavirus disease 2019: a multi-center retrospective study from Anhui, China", medRxiv 2020:2020.04.22.20071050, ~ (2020)
31. Yao XH, "A pathological report of three COVID-19 cases by minimally invasive autopsies", Zhonghua Bing Li Xue Za Zhi, 49, pp.411~417 (2020)
32. Liu F, "Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression", Int J Infect Dis, 95, pp.183~191 (2020)
33. Qin C, "Dysregulation of immune response in patients with COVID-19 in Wuhan, China", Clin Infect Dis, pp.ciaa248~ (2020)
34. Cao X, "COVID-19 : immunopathology and its implications for therapy", Nat Rev Immunol, 20, pp.269~270 (2020)
35. Papakosta D, "Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias", Respiration, 78, pp.177~184 (2009)
36. Jartti T, "Role of viral infections in the development and exacerbation of asthma in children", J Allergy Clin Immunol, 140, pp.895~906 (2017)
37. Wark PAB, "Respiratory viruses and asthma", Semin Respir Crit Care Med, 39, pp.45~55 (2018)
38. Dyer KD, "The pneumonia virus of mice(PVM)model of acute respiratory infection", Viruses, 4, pp.3494~3510 (2012)
39. Bonville CA, "Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice(PVM)model of viral bronchiolitis", Virology, 349, pp.87~95 (2006)
40. Sajuthi SP, "Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium", bioRxiv 2020:2020.04.09.034454, ~ (2020)
41. Zhang JJ, "Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China", Allergy (2020)
42. Eng SS, "The Role and immunobiology of eosinophils in the respiratory system : a comprehensive review", Clin Rev Allergy Immunol, 50, pp.140~158 (2016)
43. Li K, "Single-dose, intranasal immunization with recombinant parainfluenza virus 5 expressing middle east respiratory syndrome coronavirus(MERS-CoV)spike protein protects mice from fatal MERS-CoV infection", MBio, 11, pp.e00554~e00620 (2020)
44. de Swart RL, "Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection", Vaccine, 25, pp.8518~8528 (2007)
45. Tseng CT, "Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus", PLoS One, 7, pp.e35421~ (2012)
46. Bolles M, "A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge", J Virol, 85, pp.12201~12215 (2011)
47. Gralinski LE, "Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury", MBio, 4, pp.e00271~e00313 (2013)
48. López-Mejías R, "Influence of MUC5B gene on antisynthetase syndrome", Sci Rep, 10, pp.1415~ (2020)
49. Ley B, "The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis : an observational cohort-control study", Lancet Respir Med, 5, pp.639~647 (2017)
50. Ley B, "Rare protein-altering telomere-related gene variants in patients with chronic hypersensitivity pneumonitis", Am J Respir Crit Care Med, 200, pp.1154~1163 (2019)
51. Bouros D, "Telomeropathy in chronic hypersensitivity pneumonitis", Am J Respir Crit Care Med, 200, pp.1086~1087 (2019)
52. Courtwright AM, "Telomeres in interstitial lung disease : The short and the long of it", Ann Am Thorac Soc, 16, pp.175~181 (2019)
53. Wang J, "Genetic variability of T cell responses in hypersensitivity pneumonitis identified using the BXD genetic reference panel", Am J Physiol Lung Cell Mol Physiol, 318, pp.L631~L643 (2020)
54. Sprunger DB, "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease", Eur Respir J, 39, pp.125~132 (2012)
55. Morimoto Y, "Amphiregulin-producing pathogenic memory T helper 2 cells instruct eosinophils to secrete osteopontin and facilitate airway fibrosis", Immunity, 49, pp.134~150 (2018)
56. Liao M, "The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing", medRxiv 2020:2020.02.23.20026690, ~ (2020)
57. Zhang Y, "Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19", J Infect Dis, 222, pp.34~37 (2020)
58. Poddar S, "The interferon-stimulated gene IFITM3 restricts infection and pathogenesis of arthritogenic and encephalitic alphaviruses", J Virol, 90, pp.8780~8794 (2016)
59. Yánez DC, "IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation", Eur J Immunol, 49, pp.66~78 (2019)
60. Lindsley AW, "Eosinophil responses during COVID-19 infections and coronavirus vaccination", J Allergy Clin Immunol, 146, pp.1~7 (2020)
61. Chen WH, "The SARS-CoV-2 vaccine pipeline : an overview", Curr Trop Med Rep, pp.1~4 (2020)
62. Groot Kormelink T, "Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis", PLoS One, 6, pp.e25392~ (2011)
63. Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
64. Lima MS, "Subacute and chronic hypersensitivity pneumonitis : histopathological patterns and survival", Respir Med, 103, pp.508~515 (2009)
65. Günther A, "Surfactant alteration and replacement in acute respiratory distress syndrome", Respir Res, 2, pp.353~364 (2001)
66. Takemura T, "Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis", usual interstitial pneumonia, 2012, pp.61, 1026~1035
67. Wang J, "Advances in the research of mechanism of pulmonary fibrosis induced by corona virus disease 2019 and the corresponding therapeutic measures", Zhonghua Shao Shang Za Zhi, 36, pp.E006~ (2020)
68. Bernheim A, "Chest CT findings in coronavirus disease-19(COVID-19) : relationship to duration of infection", Radiology, pp.200463~ (2020)
69. Lal A, "Recurrent pulmonary embolism and hypersensitivity pneumonitis secondary to aspergillus, in a compost plant worker : case report and review of literature", Lung, 196, pp.553~560 (2018)
70. Faverio P, "Management of acute respiratory failure in interstitial lung diseases : overview and clinical insights", BMC Pulm Med, 18, pp.70~ (2018)

관련 논문AI추천